Avoid chasing the recent rallies in Hyperliquid (HYPE) and Nebius (NBIS), as both assets require at least a 30% correction to reach attractive entry points. Instead, pivot to SoFi Technologies (SOFI), which is currently down 42% from recent highs and represents a "coiled spring" with a long-term price target of $30. For deep value, Hims & Hers Health (HIMS) and Real Brokerage (REAX) are considered "dirt cheap" opportunities where market skepticism over acquisitions has created significant valuation gaps. Investors seeking high-growth international exposure should look at Kaspi.kz (KSPI) for its 8% dividend yield or MercadoLibre (MELI), which is currently trading at a more attractive valuation than NuBank. Finally, Meta Platforms (META) remains the highest conviction "anchor" for any portfolio, offering the cheapest entry point among the Magnificent 7 with strong catalysts in AI and hardware.

Hyperliquid (HYPE)

• The asset has surged 85% in just over a month, which the analyst describes as "casino-like" price action. • Despite liking the project, the analyst is not building a position here because the rapid move prevents a focus on fundamentals. • Risk Factor: High volatility; the analyst warns that assets capable of 6x gains in a year can also drop 80% just as quickly.

Takeaways

• Avoid Chasing: Do not FOMO into the current rally; wait for the "hype" to settle to better evaluate the long-term fundamentals. • Wait for Correction: The analyst is looking for a 30% correction before considering an entry.

Nebius (NBIS)

• A former "channel favorite" that has performed exceptionally well, returning 7x (700%) in a little over a year. • The analyst believes the stock is currently "getting out of hand" and moving too fast for disciplined position building.

Takeaways

• Exercise Caution: Follow the Warren Buffett mantra: "Be fearful when others are greedy." • Price Target for Entry: Like Hyperliquid, the analyst is waiting for a significant 30% pullback before adding more.

SoFi Technologies (SOFI)

• Identified as a stock "left behind," currently down 42% from its November 2025 highs. • Context: The price drop is attributed to "multiple compression" driven by macro fears (interest rates and Middle East tensions) rather than business failure. • Fundamentals: Top-line growth remains strong at 30%; the business is increasing book value and generating significant fee-based revenue that is not interest-rate dependent. • Insider Activity: Recent insider buying was noted, signaling management confidence.

Takeaways

• Bullish Sentiment: The analyst prefers SOFI over NuBank currently due to upcoming election risks and interest rate caps in Brazil. • Recovery Potential: Viewed as a "coiled spring" that could return to $30 if macro tensions ease and inflation/rates trend downward.

Hims & Hers Health (HIMS)

• Described as "dirt cheap" with an EV/GP/RG metric of 0.11. • The market is allegedly ignoring the Eucalyptus acquisition, which is expected to contribute $450 million in Annual Recurring Revenue (ARR) in H2 2025. • The stock is down 50% compared to a year ago, despite "firing on all cylinders."

Takeaways

• Long-term Buy: This is the analyst's preferred style of investment—a stock that provides regular opportunities to add to a position over time without "gapping up" too quickly.

Real Brokerage (REAX)

• Currently "left for dead" due to the stagnant real estate market and high mortgage rates (7-8%). • Key Catalyst: The acquisition of RE-MAX is expected to double their revenue, potentially pushing growth to 150%, though the market is currently skeptical of the deal. • Valuation: Trading at an extremely low EV/GP/RG of 0.03.

Takeaways

• Sector Play: The analyst views this as a superior platform to Opendoor (OPEN). • Contrarian Opportunity: While the market dislikes the acquisition, the analyst views it as a "clean" transaction that provides massive scale at a cheap valuation.

Kaspi.kz (KSPI)

• A "super app" dominant in Kazakhstan that is now expanding into Turkey (a market 4x larger). • Financials: Boasts a 56% profit margin and 32% top-line growth. • Valuation: Extremely low EV/GP/RG of 0.08 with a "Rule of 40" score of 88.

Takeaways

• Income + Growth: Offers a rare combination of high growth and a high dividend yield (approx. 8%). • Niche Opportunity: A strong play for investors looking for international exposure outside of US tech.

MercadoLibre (MELI)

• The analyst views MELI as the winner of the Latin American e-commerce and fintech war, outperforming both Amazon and Sea Limited in the region. • Valuation: Trading at a metric of 0.17, making it cheaper than NuBank.

Takeaways

• Preferred LatAm Play: If choosing one stock for Latin American exposure, the analyst selects MELI over NU due to its valuation and compounding potential.

Meta Platforms (META)

• Labeled the "cheapest of the Magnificent 7" and a "pristine collateral" asset. • Growth: Expected to grow revenue by 22% over the next 12 months. • Catalysts: * AI Integration: Improving ad effectiveness and user addiction. * Monetization: The launch of "Instagram Plus" (subscription model). * Hardware: Success of the Ray-Ban Meta glasses. * Cyclical Upside: Increased ad spend during the upcoming midterm elections.

Takeaways

• Portfolio Anchor: Recommended as a defensive "anchor" during a market crash because it is high-quality collateral and has not run up as much as NVIDIA. • Bullish Sentiment: Viewed as a "must-own" for those seeking AI exposure without the extreme premiums of other chip or software stocks.